# Keycorp: overview

KEY · NYSE · CIK 91576 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/key.md) · [Financials](/companies/key/financials.md) · [Filings](/companies/key/filings.md) · [Insiders](/companies/key/insiders.md)

Latest reported revenue: [$449.0m](/filings/0001628280-26-052671.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-052671).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [419](/filings/0001628280-25-048757.md) | [448 d](/filings/0001628280-26-010546.md) | [411](/filings/0001628280-26-030507.md) | [425](/filings/0001628280-26-052671.md) | [433](/filings/0001628280-25-048757.md) | [477 d](/filings/0001628280-26-010546.md) | [462](/filings/0001628280-26-030507.md) | [449](/filings/0001628280-26-052671.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(97.9%)](/filings/0001628280-25-048757.md) | [(54.5%) d](/filings/0001628280-26-010546.md) | [98.5%](/filings/0001628280-26-030507.md) | [100.0%](/filings/0001628280-26-052671.md) | [112.9%](/filings/0001628280-25-048757.md) | [106.9% d](/filings/0001628280-26-010546.md) | [113.0%](/filings/0001628280-26-030507.md) | [113.4%](/filings/0001628280-26-052671.md) |
| Diluted EPS | $ per share | [(0.47)](/filings/0001628280-25-048757.md) | not reported | [0.33](/filings/0001628280-26-030507.md) | [0.35](/filings/0001628280-26-052671.md) | [0.41](/filings/0001628280-25-048757.md) | not reported | [0.44](/filings/0001628280-26-030507.md) | [0.44](/filings/0001628280-26-052671.md) |
| Free cash flow | $m | [(1,222) d](/filings/0001628280-25-048757.md) | [1,704 d](/filings/0001628280-26-010546.md) | [(150)](/filings/0001628280-26-030507.md) | [1,211 d](/filings/0001628280-26-052671.md) | [367 d](/filings/0001628280-25-048757.md) | [673 d](/filings/0001628280-26-010546.md) | [(74.0)](/filings/0001628280-26-030507.md) | [233 d](/filings/0001628280-26-052671.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,823](/filings/0000091576-23-000026.md) | [1,594](/filings/0000091576-25-000038.md) | [1,435](/filings/0001628280-26-010546.md) | [1,643](/filings/0001628280-26-010546.md) | [1,749](/filings/0001628280-26-010546.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [144.0%](/filings/0000091576-24-000040.md) | [120.3%](/filings/0000091576-25-000038.md) | [67.4%](/filings/0001628280-26-010546.md) | [(9.8%)](/filings/0001628280-26-010546.md) | [104.6%](/filings/0001628280-26-010546.md) |
| Diluted EPS | $ per share | [2.63](/filings/0000091576-24-000040.md) | [1.93](/filings/0000091576-25-000038.md) | [0.88](/filings/0001628280-26-010546.md) | [(0.32)](/filings/0001628280-26-010546.md) | [1.52](/filings/0001628280-26-010546.md) |
| Free cash flow | $m | [1,087](/filings/0000091576-24-000040.md) | [4,373](/filings/0000091576-25-000038.md) | [2,761](/filings/0001628280-26-010546.md) | [599](/filings/0001628280-26-010546.md) | [2,101](/filings/0001628280-26-010546.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/key/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2025-02-05 | [Bank of Nova Scotia](/insiders/9631.md) | Director, 10% owner | Purchase (P) | 50,000 | $17.85 | $892.5k | [Form 4](/filings/0000950157-25-000113.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BANK OF NOVA SCOTIA](/funds/9631.md) | 2026-06-30 | $3.64bn | 157,762,958 |  | Reduced −5,233,368 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.04bn | 88,464,784 |  | Reduced −257,893 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.51bn | 65,486,394 |  | Reduced −394,992 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.20bn | 51,860,583 |  | Added +375,511 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.18bn | 51,368,660 |  | Added +4,238,225 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.16bn | 50,275,640 |  | Added +3,540,696 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $588.3m | 25,619,560 |  | Added +194,265 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $481.5m | 20,889,560 |  | Added +1,654,097 |
| [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $380.2m | 16,496,467 |  | Added +6,543,919 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $342.2m | 14,847,409 |  | Added +352,551 |

## Recent filings

[All 2,444 filings](/companies/key/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 06:30 ET | [8-K](/filings/0000091576-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000091576-26-000020 |
| 2026-09-25 | 17:04 ET | [8-K](/filings/0001628280-26-063618.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-063618 |
| 2026-09-14 | 07:56 ET | [8-K](/filings/0001628280-26-061680.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-061680 |
| 2026-08-14 | 16:20 ET | [8-K](/filings/0001628280-26-057141.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-057141 |
| 2026-08-04 | 16:47 ET | [10-Q](/filings/0001628280-26-052671.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052671 |
| 2026-07-21 | 06:31 ET | [8-K](/filings/0000091576-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000091576-26-000017 |
| 2026-06-10 | 16:08 ET | [8-K](/filings/0001193125-26-265823.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-265823 |
| 2026-06-03 | 17:12 ET | [8-K](/filings/0001628280-26-040502.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-040502 |
| 2026-05-29 | 17:12 ET | [8-K](/filings/0001628280-26-039245.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-039245 |
| 2026-05-14 | 16:02 ET | [8-K](/filings/0001628280-26-035060.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-035060 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-010546.md), filed Feb 23, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 91576
- Tickers: KEY, KEY-PK, KEY-PI, KEY-PJ, KEY-PL
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:30 ET. No prices; not investment advice.